[Acute promyelocytic leukemia: confirmation of the therapeutic value of the cytosine arabinoside-thioguanine combination].
D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D013866:Thioguanine / Q000009:adverse effects / Q000627:therapeutic use*
D003561:Cytarabine; D013866:Thioguanine
Leucosi acuta a promielociti: conferma della validità terapeutica della associazione citosin-arabinoside, tioguanina